Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stephen Lieber On Taking The Right Steps On National Health Care Technology Goals: An Interview With PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Technology to manage health care is growing in sophistication and use, presenting sharp challenges to manage almost every aspect of the interaction between patients and health care providers. The Health Information Management Systems Society is looking closely at the issues of eHealth and spoke to PharmAsia News about implementation in Asia.

You may also be interested in...



Southeast Asian Regulators Ramp Up Anti-Corruption, Bribery Enforcement Ahead of ASEAN Pact

Regulators in Southeast Asia are working to tighten bribery and corruption enforcement as part of a broader push ahead of an Association of Southeast Asian Nations trade pact in 2015 for greater transparency in pharmaceuticals.

St. Jude Introduces Allure Quadra To Hong Kong As It Seeks APAC Rebound For Pacemakers

The first commercial implant for St. Jude’s Allure Quadra in Hong Kong is a sign for optimism for its pacemaker business after last year’s disappointments in Japan.

Millennium Development Goals For Emerging Markets Off The Mark

Some health-focused Millennium Development Goals are likely to fail to reach a successful benchmark by 2015. Companies are exploring new partnership models for public health achievements.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC085135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel